Description |
neurocan |
tenascin R |
Image |
No pdb structure |
No pdb structure |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- 3-month functional outcome in ischaemic stroke (modified Rankin score) ( 30796134)
- Attention deficit hyperactivity disorder ( 30563984)
- Body mass index ( 26426971)
- Corneal astigmatism ( 29422769)
- Disease progression to choroidal neovascularization form in age-related macular degeneration ( 29346644)
- Liver fibrosis in non-alcoholic fatty acid liver disease ( 31311600)
- Telomere length ( 30185882)
- Tonometry ( 17903302)
|
Interacting Genes |
8 interacting genes:
CNTN2
HMGB1
L1CAM
NCAM1
PTN
PTPRF
TNC
TNR
|
16 interacting genes:
ACAN
BCAN
CCDC146
CNTN1
LGALS14
MAGEB4
NCAN
NCK2
NFASC
NTAQ1
POLR3C
PSMA1
PTPRZ1
SIGLEC1
TRIM54
VCAN
|
Entrez ID |
1463 |
7143 |
HPRD ID |
02897 |
03589 |
Ensembl ID |
ENSG00000130287
|
ENSG00000116147
|
Uniprot IDs |
A0A024R7M3
O14594
Q4LE67
|
A1L306
Q92752
|
PDB IDs |
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|